What does the Dyskeratosis Congenita Gene Panel include at Metropolis Healthcare?
It covers multiple genes associated with dyskeratosis congenita and telomere-related disorders using high-quality NGS technology.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from EDTA blood and sequences the involved genes using advanced next-generation sequencing platforms.
Who should consider taking this test at Metropolis Healthcare?
Individuals with unexplained bone marrow failure, telomere abnormalities, or a clinical suspicion of dyskeratosis congenita may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is required for accurate genetic sequencing.
How long does Metropolis Healthcare take to provide results?
Turnaround time varies depending on sequencing and analysis steps, with reports delivered as soon as evaluation is complete.
Why choose Metropolis Healthcare for this genetic test?
Metropolis Healthcare ensures comprehensive gene coverage, strict quality control, and clinically meaningful interpretation.
Does Metropolis Healthcare provide post-test interpretation support?
Yes, results include expert genetic insights to help clinicians make informed management decisions.
Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is appropriate for both pediatric and adult patients when dyskeratosis congenita is suspected.